Evidence map›Paper›PMID 35402173›Full record

ArticleTranslational cancer research2022

Multiple primary lung cancer comprised of adenocarcinoma and adenoid cystic carcinoma: a case report.

Jieyu Xu, Jinjing Wang, Chengfang Li, Jin Yao, Puyu Liu, Xiaorong Yang

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Translational cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jieyu XuDepartment of Clinical Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jinjing WangDepartment of Clinical Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Chengfang LiDepartment of Clinical Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jin YaoDepartment of Clinical Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Puyu LiuDepartment of Clinical Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Xiaorong YangDepartment of Clinical Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple primary lung cancer (MPLC) is a rare type of tumor, and it is necessary to differentiate it from a metastatic tumor. The type of adenocarcinoma with adenoid cystic carcinoma (ACC) is extremely rare and has not yet been reported in the literature. The initial clinical symptoms of double primary lung cancer may be nonspecific; hence, the diagnosis is often missed or incorrect. Case Description: In this case presentation, we report the case of a 67-year-old female who had experienced persistent cough and expectoration for 8 days. Chest computed tomography (CT) revealed 2 nodules in the patient's lung. Radiographic findings could not distinguish between the 2 nodules and between primary and metastatic lesions. Thus, the patient underwent bronchoscopic biopsy and percutaneous lung puncture. We could not determine the type of the two tumors in hematoxylin and eosin (H&E) staining sections, and we subsequently performed specific immunohistochemical (IHC) staining. Combined with morphological and IHC results, we concluded that this was a case of MPLC, consisting of adenocarcinoma and ACC. The patient received symptomatic treatment because of the metastases. Conclusions: This report reports a rare combination of MPLC and shows that a definitive diagnosis of double primary lung cancer can be based on tissue biopsy and IHC techniques.

Indexed as

adenocarcinomaadenoid cystic carcinoma (ACC)case reportimmunohistochemistryMultiple primary lung cancer (MPLC)

Identifiers

PMID35402173
PMCPMC8990866
OpenAlexW4221077253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.